India Pharma Outlook Team | Thursday, 18 September 2025
Stryker, a company that is known worldwide for its medical technologies, has made its presence known in India for the research and development area by inaugurating a new facility of 140,000 sq. ft. in Whitefield, Bengaluru. This new facility adds to the company’s already existing 220,000 sq. ft. R&D campus in Gurgaon, indicating the increased importance of India in Stryker’s global innovation strategy.
The centre will introduce new technology with robotics as the main theme, accompanied by artificial intelligence (AI), digital technologies, and product security—the combination of which is expected to make this healthcare facility the next level of the breakthrough in the medical field.
Welcome to Stryker’s healthcare innovation journey. We have done a through revamping in our medical experience centre that seeks to be not just a hub of knowledge but a place that encourages interaction between medical workers and Stryker’s environment of healthcare solutions. Starting from ICU beds and stretchers to ambulance cots and automated external defibrillators (AEDs), the centre will provide clinicians with first-hand experiences of the company’s advanced technologies.
Also Read: India emerges as leader in robotic cardiac surgery
"With a purpose, we are growing – widening our reach, building our strength as the centre of excellence for innovation, collaboration, and the delivery of customer and patient-centric solutions globally," commented Ram Rangarajan, Vice President, Stryker Global Technology Center. "The building with its sophisticated labs and concentrated attention on Digital and AI is a perfect fit for the top talent we want to attract, for the excellence we want to experience, and for the rapid innovation we want to see all while fulfilling our great healthcare mission."
